Showing 3281-3290 of 5646 results for "".
- I-MED Pharma Gains Health Canada Approval For E>Eye Laserhttps://modernod.com/news/i-med-pharma-gains-health-canada-approval-for-eeye-laser/2477656/I-MED Pharma has announced Health Canada approval for dry eye device E>Eye Laser, which is now available to Canadian eye care professionals. E>Eye, designed and manufactured in France by E-Swin, is the only CE certified medical device using patented IRPL technology developed specifi
- Forecasting the New Normal: Experts Across Eye Care Discuss COVID-19’s Impacthttps://modernod.com/news/covid-19-forecasting-the-new-normal/2477626/In a recent episode of Ophthalmology Off the Grid, cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, were joined by Iqbal Ike K. Ahmed, MD, FRCSC; John Kitchens, MD; and Justin Schweitzer, OD, to discuss COVID-19’s impact across eye care and share their predictions for how the current
- The Tests That Could Reopen the Country: How They Workhttps://modernod.com/news/the-tests-that-could-reopen-the-country-how-they-work/2477614/After weeks of sheltering in place, Americans are asking how soon we can return to a more normal life outside our homes. Much of the answer might be in a test. The first phase of testing has been about determining who has COVID-19. The next phase will be about who had it – or may
- HealthVerity Patient Confidence Index Aims to Become Bellwether Measure of Impact to Non-COVID-19 Patients and Physicianshttps://modernod.com/news/healthverity-patient-confidence-index-aims-to-become-bellwether-measure-of-impact-to-non-covid-19-patients-and-physicians/2477590/HealthVerity, a provider of privacy-protected data exchange for pharmaceutical manufacturers and insurers, announced the launch of the HealthVerity Patient Confidence Index, or HVPCI, and reported the first national benchmark score of 68. Indexed against a pre-pandemic score of 100, this level is
- I’m Laid Off/Furloughed/Fired, Now What?https://modernod.com/news/im-laid-off-furloughed-fired-now-what/2477584/
- AstraZeneca to Study BTK Inhibitor Calquence as Treatment for Cytokine Storm Associated With COVID-19 Infectionhttps://modernod.com/news/astrazeneca-to-study-btk-inhibitor-calquence-as-treatment-for-cytokine-storm-associated-with-covid-19-infection/2477575/AstraZeneca announced that it will investigate the potential of the BTK inhibitor Calquence (acalabrutinib) in the treatment of the cytokine storm associated with COVID-19 infection in severely ill patients. The company noted that the design of the CALAVI study is based on “strong scientifi
- Retina Industry Giants Temporarily Extend Payment Termshttps://modernod.com/news/retina-industry-giants-temporarily-extend-payment-terms/2477512/Genentech, Regeneron, Allergan, and Novartis are extending payment terms in response to the COVID-19 crisis. George Williams, MD, discussed the terms of extended payment by Genentech and Regeneron on a recent episode of New Retina Radio, and the details were confirmed by statements from th
- Zeiss Releases Company Update on COVID-19 Pandemichttps://modernod.com/news/zeiss-releases-company-update-on-covid-19-pandemic/2477475/In response to the spread of the novel coronavirus, Zeiss released a statement stating that it has developed comprehensive measures to protect employees and maintain smart business continuity. The statement reads: “In light of the current situation created by the COVID-19 pand
- FDA Authorizes Hand-Held COVID-19 Diagnostic Testhttps://modernod.com/news/fda-authorizes-hand-held-covid-19-diagnostic-test/2477452/In response to the coronavirus crisis, we’ve seen COVID-19 diagnostics quickly evolve from early, multistep kits to high-throughput versions to fast point-of-care tests, all in just a few weeks. Now, the FDA has granted an emergency authorization to a device that fits in the palm of you
- Zeiss Medical Technology Launches New Website “Zeiss MED Support Now”https://modernod.com/news/zeiss-medical-technology-launches-new-website-zeiss-med-support-now/2477453/Zeiss Medical Technology has launched a new website “